Saturday 17 October 2026 Export TLIS’s income statement to Excel — free account

Talis Biomedical Corporation

Talis Biomedical Corporation’s revenue for fiscal 2023 (year ended December 2023) was $2.1 million, down 55.7% from fiscal 2022. Operating cash flow growth for three consecutive years.

2.84 0.00 0.00%

Follow TLIS

Alert me

Market cap: $46.3M
P/E: 0.0×
Fwd P/E: −0.3×
Dividend yield: —
F-score: 4/9
Altman Z: −9.10
Beneish M: −4.89
Dividend safety: n/a

Overview Business Profile Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '23	Dec '23	Mar '24	Jun '24
Piotroski F-Score Full definition →	+8 more TTM periods Free account	3	4	4	—
ROE Full definition →		(64.53%)	(63.32%)	(68.60%)	(70.48%)
ROA Full definition →		(50.10%)	(46.98%)	(53.08%)	(52.13%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(89.41%)	(86.19%)	(90.34%)	(91.40%)
Average Days of Receivables Full definition →		0.83	8.55	2.21	—
Free Cash Flow per Share Full definition →		(30.81)	(29.56)	(23.95)	(22.02)
Free Cash Flow Full definition →		(56.05)	(53.73)	(43.63)	(40.12)
Capital Expenditures Full definition →		(0.63)	(0.49)	(0.43)	0.14
Other line items
Cash ROIC Full definition →		(33.06%)	(36.84%)	(34.35%)	(36.98%)
Accounts Receivable Turnover Full definition →		10.03	11.92	14.87	—
Accounts Payable Turnover Full definition →		0.69	0.02	0.01	0.00
Inventory Turnover Full definition →		0.00	0.00	0.00	—
Average Days of Payables Full definition →		416.24	11,920.37	48,923.52	0.00
Days of Inventory on Hand Full definition →		0.00	0.00	0.00	—
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		2,181.01%	1,906.94%	2,975.83%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		1,475.77%	1,322.12%	3,383.82%	0.00%
Share Based Compensation of Revenue Full definition →		210.06%	203.89%	381.09%	0.00%
Operating CF/Net income Full definition →		0.73	0.86	0.76	0.79
Depreciation/Fixed assets Full definition →		1.24	0.25	0.53	1.82
Capex/Depreciation Full definition →		(0.15)	(0.63)	(0.50)	0.18
Revenue per Share Full definition →		1.21	1.17	0.54	0.00
Operating CF per Share Full definition →		(30.47)	(29.29)	(23.71)	(22.09)
Capex per Share Full definition →		(0.35)	(0.27)	(0.24)	0.08
Capex to Sales Full definition →		0.29	0.23	0.44	0.00

Show all line items

Columns are period end dates

Stockrow Weekly